MegaFood Baby and Me 2 Lawsuit: Claims, Testing, and Response

The MegaFood Baby and Me 2 lawsuit is a proposed class action claiming the prenatal vitamin contains undisclosed lead, arsenic, cadmium, and mercury, and that manufacturer FoodState, Inc. sold it as a clean, whole-food supplement without warning pregnant consumers about the contamination. As of mid-2026, the case is in discovery and class certification. No class has been certified, no settlement has been reached, and no recall has been issued.¹

What Plaintiffs Are Claiming

The complaint says independent lab testing detected four heavy metals in Baby and Me 2 at levels the plaintiffs argue exceed what medical experts consider safe for fetal development. MegaFood, they allege, never disclosed those contaminants on the label or in its marketing, while promoting the product as a “real food” prenatal.¹

The legal theories in the complaint include deceptive marketing under consumer protection statutes, product liability for a supplement alleged to be “unreasonably dangerous,” breach of the warranty implied by the whole-food branding, negligence and fraud in the label omissions, and unjust enrichment from selling a product the company allegedly knew or should have known was contaminated. Plaintiffs emphasize that the intended consumers are pregnant women and developing fetuses, which they argue makes the omissions especially harmful.¹

The Testing Behind the Allegations

The testing that drew attention to the product came from Lead Safe Mama, a consumer advocacy organization run by Tamara Rubin. Of eleven prenatal vitamins the group tested, Baby and Me 2 was one of only two that tested positive for mercury, and the group described the mercury level as “significantly higher” than the only other prenatal in its database with detectable mercury.²

Figures circulating in consumer discussions of the results put the product at 62 ppb lead, 67 ppb cadmium, 13 ppb mercury, and 27 ppb arsenic.³ The International Federation of Gynecology and Obstetrics recommends less than 10 ppb for lead, less than 10 ppb for arsenic, and less than 5 ppb for cadmium in prenatal vitamins.⁴ Measured against those thresholds, the reported lead figure would be more than six times the ceiling and the cadmium figure more than thirteen times.

Rubin has recommended that anyone who has been taking the supplement talk to their doctor about blood or urine heavy metals testing.²

Why Heavy Metals in a Prenatal Matter

Lead, arsenic, and cadmium can cross the placental barrier. A peer-reviewed study published through the National Institutes of Health links arsenic exposure during pregnancy to miscarriage, stillbirth, and infant mortality, and links cadmium and lead exposure to low birth weight, short birth length, and small head circumference. Childhood lead exposure is also associated with brain and nervous system damage, learning deficits, and hearing disorders.⁵

The CDC has warned that heavy metals can affect a developing brain and can enter breast milk, with potential long-term neurodevelopmental effects.⁶ FIGO has said that even “small exposures to toxic chemicals during pregnancy can trigger adverse health consequences.”⁴

MegaFood’s Response

The named defendant is FoodState, Inc., a New Hampshire corporation doing business as MegaFood. FoodState is a wholly owned subsidiary of Pharmavite LLC, which is itself a subsidiary of Otsuka Pharmaceutical Co., Ltd.⁷ MegaFood is a Certified B Corporation and states that it uses NSF GMP-certified quality management and ISO-certified laboratory testing.⁸

As of mid-2026, MegaFood has not recalled the product, reformulated it, or issued a public statement addressing the heavy metals allegations. Baby and Me 2 is still on the shelf. In court, the company has pushed back on class certification, arguing that individual consumer experiences are too varied to be grouped together.¹

Where the Case Stands

The case is in the discovery and class certification phase as of June 2026. Plaintiffs’ attorneys have moved for class certification and the court has not yet ruled. No settlement has been announced, and the FDA has not recalled the product.¹

Any serious settlement talks would likely follow the certification ruling. Based on comparable supplement class actions, potential payouts could range from $25 to $200 for purchase-based claims, $200 to $2,000 for claims supported by medical documentation, and higher amounts for serious documented harm. Class members would need to file a claim, and attorneys’ fees in these settlements typically consume 25% to 33% of the fund.¹

The Regulatory Backdrop

One reason cases like this end up in civil court is that no federal rule sets specific limits on lead, arsenic, cadmium, or mercury in dietary supplements, and over-the-counter prenatals do not require FDA approval before reaching store shelves.⁵ The Center for Science in the Public Interest has said flatly that “there are currently no federal regulations to limit heavy metal contamination in baby food or prenatal vitamins.”⁹

California has gone further. Proposition 65 already requires warnings about reproductive toxicants and sets a lead exposure limit of 0.5 micrograms per day for reproductive toxicity. California’s Senate Bill 646, in its third reading as of mid-2026, would require prenatal vitamin manufacturers to test each lot for arsenic, cadmium, lead, and mercury at accredited laboratories, post the results online, and include a QR code linking to the data on labels. If enacted, compliance would be required starting January 1, 2027.¹⁰

1
LawFold. MegaFood Baby and Me 2 Lawsuit
2
Lead Safe Mama. MegaFood Baby Me2 Prenatal Multi
3
JustAnswer. Test Results Showing Heavy Metals
4
FIGO. Toxic Chemicals and Environmental Contaminants in Prenatal Vitamins
5
National Library of Medicine. Heavy Metals in Prenatal Vitamins
6
CDC. Lead and Metals in Reproductive Health
7
MegaFood. Pharmavite Acquires Whole Food Supplement Innovator FoodState
8
Pharmavite. MegaFood
9
CSPI. CA Legislature Passes Bill Protect Against Toxic Heavy Metals Prenatal Vitamins
10
California Legislature. SB 646 Analysis